Suppr超能文献

C反应蛋白/白蛋白比值在胃癌中的临床意义及预后价值

Clinical significance and prognostic value of C-reactive protein/albumin ratio in gastric cancer.

作者信息

Yu Qian, Li Ke-Zhi, Fu Yan-Jun, Tang Yanping, Liang Xin-Qiang, Liang Zhi-Qing, Bai Ji-Hong

机构信息

Department of Pharmaceutics, Affiliated Hospital of Guilin Medical University, Guilin, China.

Department of Research, Guangxi Medical University Cancer Hospital, Nanning, China.

出版信息

Ann Surg Treat Res. 2021 Jun;100(6):338-346. doi: 10.4174/astr.2021.100.6.338. Epub 2021 Jun 1.

Abstract

PURPOSE

This study was aimed to evaluate the clinical significance and prognostic value of CRP/albumin ratio (CAR) in patients with gastric cancer.

METHODS

The data of 205 gastric cancer patients who underwent surgery was analyzed retrospectively. The association of CAR with the clinical features and prognostic value in gastric cancer was analyzed. The data of this study was combined with previous studies to further determine the prognostic value of CAR in patients with gastric cancer using a meta-analysis method.

RESULTS

Cox analysis revealed that preoperative CAR was an independent prognosis indicator in patients with gastric cancer. High expression of CAR indicated a shorter survival time than in those with lower expression. CAR has a higher prognostic value in the 1-, 3-, and 5-year overall survival in patients with gastric cancer. CAR showed significant difference regarding the gastric cancer patients' age, M stage, and clinical stage. The discriminate value of CAR in M stage of gastric cancer was high (area under the curve, 0.809). A meta-analysis combining previous data and our data showed that preoperative CAR demonstrated a significant association with the overall survival of patients with gastric cancer.

CONCLUSION

This study demonstrated that preoperative CAR could serve as an important prognostic indicator in patients with gastric cancer.

摘要

目的

本研究旨在评估胃癌患者中C反应蛋白/白蛋白比值(CAR)的临床意义及预后价值。

方法

回顾性分析205例行手术治疗的胃癌患者的数据。分析CAR与胃癌临床特征及预后价值的相关性。将本研究数据与既往研究相结合,采用Meta分析方法进一步确定CAR在胃癌患者中的预后价值。

结果

Cox分析显示,术前CAR是胃癌患者的独立预后指标。CAR高表达患者的生存时间短于低表达患者。CAR对胃癌患者1年、3年和5年总生存具有较高的预后价值。CAR在胃癌患者的年龄、M分期和临床分期方面存在显著差异。CAR在胃癌M分期中的鉴别价值较高(曲线下面积为0.809)。将既往数据与本研究数据进行Meta分析显示,术前CAR与胃癌患者的总生存显著相关。

结论

本研究表明,术前CAR可作为胃癌患者重要的预后指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac6b/8176197/f000a7286c2f/astr-100-338-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验